London is perhaps one the last places in the UK that people would regard as having poor connectivity, yet a number of its regions suffer from lack of adequate mobile coverage and gigabit access. As a ...

Please provide your email address to receive an email when new articles are posted on . Harrow will inherit MELT-300, a sublingually delivered sedation product. The company plans to submit a new drug ...

Nashville-based eye care pharmaceutical company Harrow Inc. reported mixed results for the third quarter on Monday, with earnings that beat analysts' expectations and revenue that fell short of ...

Americans hoping to give their offspring a very British education – without the transatlantic flight – are now in luck: Harrow School, a bastion of learning and the alma mater of Sir Winston Churchill ...

Investing.com -- Harrow Health, Inc. (NASDAQ:HROW), a provider of ophthalmic disease management solutions, reported third-quarter earnings that beat analyst expectations, but shares tumbled 14% in ...

A north London borough that is due to see its last police station front desk close plans to launch legal proceedings against the mayor of London and Met Police. Harrow Council leader Paul Osborn ...

Harrow Council plans legal action against Mayor Sadiq Khan over the closure of Pinner Police Station’s volunteer-run front desk, which would leave the borough without any in-person police counter.

A Harrow resident has claimed this has been the "worst year" he has experienced for fireworks being used in a dangerous or antisocial way. Brandon To, who sits on the Roxborough Residents' Association ...

Harrow's recent debt refinancing, Melt Pharmaceuticals acquisition plans, and updated peak sales estimates reinforce the bullish thesis. Base case DCF modeling projects significant revenue growth ...

All the Latest Game Footage and Images from Mutual Harrow Guide Mina and Rex through a dark and intense psychological visual novel of trauma, love, and insecurity. Traverse Section 56’s dangers, ...

In late September 2025, Harrow, Inc. launched the Harrow Access for All (HAFA) program, expanding affordable and predictable pricing for its full portfolio of branded, generic, and compounded ...

Please provide your email address to receive an email when new articles are posted on . Harrow plans to submit a new drug application in 2027 for sublingual MELT-300 for sedation and analgesia.